Cargando…
Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression
BACKGROUND: LIM kinase 1 (LIMK1) is expressed in both cytoplasmic and nuclear compartments, and is a key regulator of cytoskeletal organization involved in cell migration and proliferation. LIMK1 levels are increased in several human cancers, with LIMK1 over-expression in prostate and breast cancer...
Autores principales: | McConnell, Brice V, Koto, Karen, Gutierrez-Hartmann, Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131252/ https://www.ncbi.nlm.nih.gov/pubmed/21682918 http://dx.doi.org/10.1186/1476-4598-10-75 |
Ejemplares similares
-
Imbalanced LIMK1 and LIMK2 expression leads to human colorectal cancer progression and metastasis via promoting β-catenin nuclear translocation
por: Zhang, Yue, et al.
Publicado: (2018) -
Phospholipase C-η2 interacts with nuclear and cytoplasmic LIMK-1 during retinoic acid-stimulated neurite growth
por: Arastoo, Mohammed, et al.
Publicado: (2015) -
Erratum to: Phospholipase C-η2 interacts with nuclear and cytoplasmic LIMK-1 during retinoic acid-stimulated neurite growth
por: Arastoo, Mohammed, et al.
Publicado: (2016) -
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
por: Malvi, Parmanand, et al.
Publicado: (2020) -
Deletion of Limk1 and Limk2 in mice does not alter cochlear development or auditory function
por: Fang, Qiaojun, et al.
Publicado: (2019)